Alcobra to stop testing sole drug for ADHD after study fails

(Reuters) - Alcobra Ltd said it would abandon evaluating its only experimental drug to treat attention deficit hyperactivity disorder (ADHD), after a failed late-stage study, wiping away more than half the company's value before the bell on Tuesday.

Source: Reuters: Health - January 17, 2017 Category: Consumer Health News Tags: healthNews Source Type: news